Nothing Special   »   [go: up one dir, main page]

Mauger et al., 1978 - Google Patents

Pharmacology of the adrenoceptors and cholinoceptors of the BC3H1 nonfusing muscle cell line.

Mauger et al., 1978

View PDF @Full View
Document ID
1843030590069648476
Author
Mauger J
Moura A
Worcel M
Publication year
Publication venue
British Journal of Pharmacology

External Links

Snippet

We have studied the action of different transmitters on the transmembrane 42K or 86Rb efflux from tissue cultures of the BC3H1 muscle cell line. 2. The effect of catecholamines and carbachol (CCh) on the isotope efflux rate was measured by addition of the drugs at different …
Continue reading at www.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells

Similar Documents

Publication Publication Date Title
Paton et al. The uptake of atropine and related drugs by intestinal smooth muscle of the guinea-pig in relation to acetylcholine receptors
Greenberg et al. Alpha-noradrenergic receptor binding in mammalian brain: differential labeling of agonist and antagonist states
Adeagbo et al. Varying extracellular [K+]: a functional approach to separating EDHF-and EDNO-related mechanisms in perfused rat mesenteric arterial bed
Tohmeh et al. Biphasic adrenergic modulation of β-adrenergic receptors in man: Agonist-induced early increment and late decrement in β-adrenergic receptor number
Green et al. Transvascular flux and tissue accrual of Evans blue: effects of endotoxin and histamine
Stephans et al. Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex
Li et al. ATP P2× Receptors and Sensory Synaptic Transmission Between Primary Afferent Fibers and Spinal Dorsal Horn Neurons in Rats
Pittman et al. Ontogeny of β1-and β2-adrenergic receptors in rat cerebellum and cerebral cortex
Mauger et al. Pharmacology of the adrenoceptors and cholinoceptors of the BC3H1 nonfusing muscle cell line.
Serra et al. The intact human neuroblastoma cell (SH‐SY5Y) exhibits high‐affinity [3H] pirenzepine binding associated with hydrolysis of phosphatidylinositols
Barrett et al. Alpha and beta adrenergic receptor activity in fetal sheep
Roshanravan et al. NMDA receptors as potential therapeutic targets in diabetic nephropathy: increased renal NMDA receptor subunit expression in Akita mice and reduced nephropathy following sustained treatment with memantine or MK-801
Nayler et al. Effect of ischaemia on cardiac contractility and calcium exchangeability
Palade et al. Slow calcium and potassium currents in frog skeletal muscle: their relationship and pharmacologic properties
Gyawali et al. Involvement of a novel organic cation transporter in paeonol transport across the blood-brain barrier
Cacini et al. Accumulation of cimetidine by kidney cortex slices.
Calder et al. Potassium channel opening properties of thiazide diuretics in isolated guinea pig resistance arteries
Grassi et al. Blockage of nicotinic acetylcholine receptors by 5‐hydroxytryptamine
Madelian et al. Beta-receptor-stimulated and cyclic adenosine 3', 5'-monophosphate-mediated taurine release from LRM55 glial cells
Cook et al. The effects of methamphetamine on behavior and on the uptake, release and metabolism of norepinephrine
DK2421519T3 (en) NMDA RECEPTOR BLOCKERS FOR THE TREATMENT OF SEAL CELL ANAEMS
Luxon et al. A new method for quantitating intracellular transport: application to the thyroid hormone 3, 5, 3'-triiodothyronine
He et al. β‐adrenergic control of cell volume and chloride transport in an established rat submandibular cell line
Lee et al. P2Y receptor regulation of sodium transport in human mammary epithelial cells
US4128399A (en) Device and method for detecting phenothiazine-type drugs in urine